Discussion
Diagnosis With Brief Discussion
- Diagnosis
- Diffuse alveolar hemorrhage induced by inhaled Sevoflurane
- Radiologic Findings
- Fig. 1 Chest PA shows multiple patchy opacities in both lung fields.
Fig. 2-4 CT scans demonstrates multifocal patchy consolidation and ill defined GGO in both lungs.
Fig. 5 Chest PA shows the disappearance of multiple patchy opacities in both lung fields 2 days later.
- Brief Review
- Sevoflurane is an inhalational anesthetic agent used to induce and maintain general anesthesia. When metabolized, sevoflurane primarily produces two compounds: Compound A (fluoromethyl-2,2-difluoro-1-(trifluoromethyl) vinyl ether) and Compound B (1,1,1,3,3-Penta fluoro-2-(fluoromethoxy)-3-methoxy-propane). Compound A causes direct renal toxicity, and although the relationship between Compound A and pulmonary toxicity has not been studied, this toxic metabolite may be associated with damage to the alveolar-capillary membrane. Additionally, it is known that other volatile gases can induce pulmonary inflammation and endothelial damage by activating the arachidonic acid cascade. Sevoflurane may have similar mechanisms, potentially increasing alveolar permeability, pulmonary vasoconstriction, and oxidative stress, ultimately triggering an inflammatory response.
The possibility of sevoflurane-induced DAH should be contemplated in patients who manifest hemoptysis, hypoxemia, dyspnea, or radiological evidence of alveolar infiltrates after surgery, following the exclusion of other potential causes. Swift identification of the etiology and initiation of supportive treatment is essential for ensuring the patient's survival.
- References
- Jordan JH, Pedroza S, Billefals ES, Cruz G. Diffuse alveolar hemorrhage induced by inhaled Sevoflurane. Case report and literature review. Respir Med Case Rep. 2023 Aug 6;45:101906.
- Keywords